News & Updates
Filter by Specialty:
Antiseizure drug yields durable seizure frequency reduction, lowers concomitant medication burden
12 Nov 2021
byJairia Dela Cruz
In the treatment of adults with uncontrolled focal seizures, the long-term, open-label use of cenobamate appears to produce high rates of sustained 100-percent and ≥90-percent seizure reduction, with parallel decreases in concomitant antiseizure medication (ASM) doses, according to two separate post hoc analyses of a phase III C021 trial.
Antiseizure drug yields durable seizure frequency reduction, lowers concomitant medication burden
12 Nov 2021
Belimumab after rituximab reduces risk for severe flare in SLE
10 Nov 2021
Treatment with belimumab following rituximab significantly lowers serum IgG anti-dsDNA antibody levels and the risk for severe flare in patients with systemic lupus erythematosus (SLE) that is refractory to conventional therapy, reveals a study.